摘要 : The treatment of multiple myeloma has evolved markedly in the last decade, but mortality remains high, emphasizing the need for more effective therapies. Daratumumab, a fully human monoclonal antibody targeting CD38, has shown cli... 展开
作者 | Nadine Abdallah Shaji K. Kumar |
---|---|
作者单位 | |
期刊名称 | 《Therapeutic advances in hematology.》 |
总页数 | 18 |
语种/中图分类号 | 英语 / R5 |
关键词 | daratumumab newly diagnosed multiple myeloma untreated multiple myeloma |
馆藏号 | N2012EPST0000297 |